16Jan/13

Stealth Peptides Initiates Patient Enrollment for Novel Treatment of Acute … – PharmaLive (press release) (subscription)

Stealth Peptides Initiates Patient Enrollment for Novel Treatment of Acute
PharmaLive (press release) (subscription)
Stealth Peptides Initiates Patient Enrollment for Novel Treatment of Acute Kidney Injury Research for acute and chronic kidney disease has demonstrated Bendavia’s beneficial renal effects and confirmed the significance of its novel mechanism of

and more »

16Jan/13

Need for global policy innovation to tackle the "Silent Pandemic" that is … – The Pharma Letter

Need for global policy innovation to tackle the “Silent Pandemic” that is
The Pharma Letter
HCV is also the leading cause of liver transplantation worldwide and in the US the disease now accounts for more deaths than HIV. “The report highlights that, worldwide, despite the significant burden of HCV, governments have failed to get a grip on